腹腔镜不可见但可触及的肠道子宫内膜异位卫星病灶
本研究为单臂观察性研究,纳入51例因深部浸润型子宫内膜异位症行腹腔镜辅助肠段切除的患者,发现25.5%存在腹腔镜不可见但可触及的卫星病灶(最小2mm),其中14%位于或超出计划吻合器部位。所有大病灶术前MRI可见,而卫星病灶均未在MRI上识别。
要点
- 肠道内异症肠段切除时,腹腔镜不可见但可触及的卫星病灶常见,发生率为25.5%。
- 卫星病灶可小至2mm,且均未在术前MRI上识别。
- 14%的患者在计划吻合器部位或更远处存在不可见可触及病灶。
核心结论
- 腹腔镜不可见但可触及的肠道内异症卫星病灶在肠段切除患者中占25.5%,最小2mm。
- 延长切除范围以去除可触及病灶并避免吻合器部位病灶可能减少复发手术。
研究设计与样本
- 单臂观察性研究,纳入51例因深部浸润型子宫内膜异位症行腹腔镜辅助肠段切除的患者。
- 患者年龄24-49岁,在私人转诊中心接受手术。
主要发现
- 51例中13例(25.5%)存在不可见可触及卫星病灶,包括7例(14%)位于或超出计划吻合器部位。
- 49例大肠病灶中5例(10%)和14例回肠病灶中4例(28.6%)在计划吻合器部位或更远处有卫星病灶。
- 所有大病灶术前MRI可见,卫星病灶均未在MRI上识别;病灶小至2mm可触及。
临床怎么用
- 肠段切除时可通过触诊发现不可见卫星病灶,适当延长切除范围以去除病灶并避免吻合器部位病灶。
- 对于有临床显著肠道症状但腹腔镜未见病灶者,或计划再次手术者,需考虑不可见小病灶的可能。
局限性
- 观察性研究,无法确定小病灶是否引起症状或进展、稳定、消退。
- 仅分析原发病灶近端肠段,未分析远端肠段。
- 未纳入削切、盘状切除或无病灶可见的患者,未研究手辅助腹腔镜或直肠探头等额外识别技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the prevalence of laparoscopically nonvisualized palpable satellite bowel nodules at or near the planned stapler site in women undergoing segmental bowel resection for endometriosis? SUMMARY ANSWER: Overall, 13 (25.5%) of 51 patients who underwent resection had nonvisualized palpable satellite lesions as small as 2 mm, including seven (14%) who had nonvisualized palpable lesions at or beyond the planned stapler site. WHAT IS KNOWN ALREADY: Both laparoscopy and laparotomy for bowel resection are standard of care in Europe and the USA. Reoperation rates after laparoscopic bowel procedures are 1-16%. Endometriotic lesions at the stapler margin of bowel resections are associated with increased repeat surgery. Nodules of 0.1 mm to 1 cm in size were not recognized during laparoscopic bowel surgery but were recognized on histological examination. Up to 20 nodules not visualized at laparoscopy have been recognized and excised at laparotomy. Tenderness is found at up to 27 mm from a recognized lesion. The size of a lesion does not always predict its symptoms or behavior. STUDY DESIGN, SIZE, DURATION: This single-arm, observational study focused on the presence of nonvisualized palpable satellite lesions of the bowel. Fifty-one patients scheduled for laparoscopic-assisted bowel resection for deep infiltrating endometriosis with suprapubic incision for placement of the stapler's anvil and removal of the specimen in the course of routine clinical care were included. There were no additional inclusion or exclusion criteria. PARTICIPANTS/MATERIALS, SETTING, METHODS: Laparoscopic-assisted segmental bowel resection for endometriosis was performed in a private referral center on women aged 24-49 years. MAIN RESULTS AND THE ROLE OF CHANCE: Forty-nine (96.1%) of the 51 patients underwent segmental resection of the sigmoid or rectum, and 14 (27.5%) underwent segmental resection of the ileum for large nodule(s) recognized on MRI. Twelve patients underwent both procedures. Eleven (22.4%) of the 49 patients with recognized sigmoid or rectal lesions and 5 (35.7%) of the 14 patients with recognized ileal lesions had nonvisualized, palpable, satellite lesions. All the large lesions and none of the satellite lesions had been recognized preoperatively on MRI. Five (10%) of 49 patients with lesions of the large bowel and 4 (28.6%) of the 14 patients with lesions of the ileum had nonvisualized palpable satellite lesions at or beyond the planned stapler site. Lesions as small as 2 mm were palpable. LIMITATIONS, REASONS FOR CAUTION: This is an observational study. It is not known if the small lesions of this study contributed to the symptoms or were progressive, stable or regressive. This study analyzed lesions in the bowel segment proximal to the primary large bowel lesion, but not in the distal segment as that would have required a change in standard of care surgical technique. This study protocol did not include shaving or disk resection or patients in whom no lesions were visualized. The use of additional techniques for recognition, such as hand-assisted laparoscopy or rectal probes, was not investigated. WIDER IMPLICATIONS OF THE FINDINGS: This study confirms that some nonvisualized satellite lesions as small as 2 mm are palpable and that an increased length of resection can be used to remove lesions recognized by palpation and to avoid lesions at and beyond the stapler site. This may decrease recurrent surgery in 1-16% of the women undergoing surgery for bowel endometriosis. Knowledge of the occurrence of these small lesions may also be particularly useful in plans for repeat surgery or for women with clinically significant bowel symptoms and no visible lesions at laparoscopy. Moreover, small lesions are considered to be important as there is no current technique to determine whether a large primary lesion, smaller lesions, an associated adjacent tissue reaction or a combination of those cause symptoms. STUDY FUNDING/COMPETING INTEREST(S): This CIRENDO cohort was supported by the G4 Group (the University Hospitals of Rouen, Lille, Amiens and Caen) and the ROUENDOMETRIOSE association. No specific funding was received for the study. H.R. reports receiving personal fees from Plasma Surgical Inc., Ethicon Endosurgery, Olympus and Nordic Pharma for presentations related to his experience with endometriosis surgery. D.C.M. reports being given access to Lumenis Surgical CO2 Lasers' lab at a meeting. None of the other authors have conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: N/A.
引用
- Roman H, Merlot B, Forestier D, et al. Nonvisualized palpable bowel endometriotic satellites. Hum Reprod. 2021. PMID: 33432338. doi:10.1093/humrep/deaa340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。